The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terrazas, L. I.
Right arrow Articles by Harn, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terrazas, L. I.
Right arrow Articles by Harn, D. A., Jr.
The Journal of Immunology, 2001, 167: 5294-5303.
Copyright © 2001 by The American Association of Immunologists

The Schistosome Oligosaccharide Lacto-N-neotetraose Expands Gr1+ Cells That Secrete Anti-inflammatory Cytokines and Inhibit Proliferation of Naive CD4+ Cells: A Potential Mechanism for Immune Polarization in Helminth Infections

Luis I. Terrazas1,*, Kristen L. Walsh*, Danuta Piskorska{dagger}, Edward McGuire{dagger} and Donald A. Harn, Jr.*

* Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115; and {dagger} Neose Technologies Inc., Horsham, PA 19044


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Immunomodulatory oligosaccharides found on helminths also are found in human milk, and both helminths and milk have been shown to be immunosuppressive. We have been examining the immunomodulatory capabilities of two oligosaccharides expressed in milk and on helminth parasites, lacto-N-fucopentaose III and lacto-N-neotetraose (LNnT). In an attempt to dissect mechanisms that lead to Th2 polarization and immune suppression, we examined the early response in mice to the glycoconjugate LNnT-Dextran (LNnT-Dex). We found that injection of LNnT-Dex expanded a cell population, phenotypically defined as Gr1+/CD11b+/F4/80+, as early as 2 h after injection. Examination of spontaneous cytokine production showed that this Gr1+/F4/80+ population of cells spontaneously produced low levels of proinflammatory cytokines, but higher levels of IL-10 and TGF-{beta} ex vivo, compared to peritoneal cells from mice injected with Dex. Gr1+ cells adoptively suppressed naive CD4+ T cell proliferation in vitro in response to anti-CD3/CD28 Ab stimulation. Suppression of naive CD4+ cells involved cell contact and was dependent on IFN-{gamma} and NO, with a discrete role played by IL-10. Coculture of naive CD4+T cells with Gr1+ suppressor cells did not lead to CD4+ T cell apoptosis, although it did imprint on naive CD4+ T cells a response characterized by lower levels of IFN-{gamma}, coincident with increased IL-13 production. Our results suggest that both human milk and helminth parasites may share a ligand-specific mechanism involved in the generation of anti-inflammatory mediators that suppress Th1-type and inflammatory responses.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Early interactions between pathogen and host participate in the establishment of an adaptive immune response to the pathogen. The majority of microbial pathogens are potent stimulators of Th1 responses. For example, Mycobacterium, Listeria, Trypanosoma, and Toxoplasma all drive Th1-type proinflammatory responses, attributable in part to the rapid induction of IL-12 and IFN-{gamma} by innate immune cells responding to pathogen-expressed molecules termed "pathogen-associated molecular patterns" (1, 2, 3, 4, 5). In contrast, helminth infection generally biases the immune response towards a Th2-type profile and also may be associated with induction of Ag-specific or nonspecific anergy (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16). To date, other than studies on implantation of filaria in mice that demonstrate an IL-4-dependent, cell contact mechanism between regulatory and responder T cells, there is scant other information regarding how helminths drive Th2 biasing or induce suppression other than the nature of immune-biasing Ags (16). In this regard, helminth-expressed molecules that drive Th2-biasing and/or immunosuppressive responses generally have been reported as excreted/secreted products from Nippostrongylus, Toxocara, Schistosoma, and Taenia (7, 17, 18, 19).

Among helminths, schistosomes are potent Th2 drivers and inducers of immune anergy, with the parasite egg as the strongest stimulus of these responses. Of the myriad components present in schistosome eggs, carbohydrates have been shown to be largely responsible for inducing Th2, anti-inflammatory, and IgE responses (19, 20). Further, we identified two schistosome oligosaccharides, lacto-N-fucopentaose III (LNFPIII)2 and lacto-N-neotetraose (LNnT), that are Th2-biasing and capable of suppressing Th1 responses in vivo (21, 22). These two oligosaccharides also are found in human milk, which has been shown to be immunosuppressive (23). In this study, we asked if the immunomodulatory properties of the glycoconjugate LNnT-Dex, are attributable in part to activation of innate mechanisms that contribute to Th2 biasing and immune suppression. We found that injection of mice with LNnT-Dex led to a rapid "innate" expansion of cells expressing the surface markers Gr1, CD11b, and F4/80. This Gr1+ population suppressed the proliferative response of naive CD4+ T cells to primary stimulation with anti-CD3 and anti-CD28 Abs, by a mechanism that required both cell-to-cell contact and soluble factors. In addition, Gr1+ suppressor cells produced low levels of proinflammatory cytokines coincident with elevated levels of IL-10 and TGF-{beta}. Lastly, and perhaps most relevant to a mechanism that leads to a possible Th2 biasing and antiinflammatory responses, we demonstrate that LNnT-Dex Gr1+ suppressor cells were able to "imprint" a Th2 phenotype on otherwise naive CD4+ T cells.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Six- to 10-week-old female BALB/c and C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and were maintained in a pathogen-free environment at the Harvard Medical School animal facility in accordance with institutional guidelines.

Glycoconjugate injection and collection of PECs

LNnT-Dextran (LNnT-Dex) was conjugated to a 10 kDa molecule of dextran and was supplied by Neose Technologies (Horsham, PA). Three different glycoconjugates were used, having 21, 35, or 45 molecules of LNnT per molecule of dextran.

LNnT-Dex 21, 35, or 45, diluted in saline, was administered at a dose of 100 µg/mouse in all experiments. Naive BALB/c or C57BL/6 mice were injected i.p. with the LNnT-Dex, dextran, or saline, and animals were sacrificed 2 and 18 h later by CO2 inhalation.

Peritoneal exudate cells (PECs) were obtained at 2 and 18 h after injection by peritoneal lavage with 5 ml of ice-cold HBSS (Life Technologies, Rockville, MD). PECs were washed two times, and RBC were lysed by hypotonic shock with ammonium chloride. Viable cells were counted and adjusted to 5 x 105 cells/ml. Viability measured by trypan blue exclusion was routinely over 95%. PECs were analyzed for surface markers, cytokine production, and suppressor activity in cocultures with naive CD4 cells.

Flow cytometric analysis

Peritoneal exudate cells were blocked with anti-mouse Fc{gamma}R Ab (CD16/CD32) and stained with FITC-conjugated mAbs against Mac-1 (CD11b), F4/80, Gr-1 (Ly-6G), MHC-II, B7-2, or PE-conjugated Abs against Gr-1 (Ly-6G), and IL-10R. All Abs were purchased from BD PharMingen (San Diego, CA), except anti-F4/80, which was obtained from Serotec (Oxford, U.K.). Stained cells were analyzed on a FACSCalibur with CellQuest software (BD Biosciences, Mountain View, CA). Live cells were electronically gated with forward and side scatter parameters.

Cell culture and coculture of PECs-CD4+ cells

All cultures and cocultures were maintained in RPMI 1640 (Life Technologies) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin (Sigma, St. Louis, MO), 5 x 10-5 M 2-ME (Life Technologies) and 10% FBS (Hyclone Laboratories, Logan, VT). PECs were adjusted to a concentration of 5 x 105/ml, plated in 24-well plates (Costar, Cambridge, MA) and were maintained at 37°C and 5% CO2 for 72 h. Supernatants were harvested, centrifuged, and examined for spontaneous production of IFN-{gamma}, IL-12, IL-10 (Abs and cytokines were obtained from BD PharMingen), IL-1{beta}, IL-18, IL-13, and TGF-{beta} (obtained from R&D Systems, Minneapolis, MN).

Coculture of PECs with naive CD4+ cells was performed as follows: PECs were obtained as described and adjusted to 5 x 105 PECs/ml. Splenocytes were prepared from naive mice and enriched for CD4+ cells (>95% by FACS analysis) with CD4 MACS (Miltenyi Biotec, Bergisch Gladbach, Germany). CD4+ cells were plated in 96-well flat-bottom plates (Costar) that were precoated with anti-CD3 and anti-CD28 Abs (BD PharMingen) at 1 µg/ml. Three hours later, PECs were added to CD4+ T cells at ratios of from 1:4 to 1:16 (PECs:CD4+). Cultures were maintained at 37°C and 5% CO2 for 72 h, then 1 µCi/well [3H]thymidine (185 GBb/mmol activity, Amersham, Aylesbury, U.K.) was added and incubated for a further 18 h. Cells were harvested on a 96-well harvester (Tomtec, Toku, Finland) and then counted with a beta-plate counter. Values are represented as cpm from triplicate wells. In some experiments, supernatants from cocultures were harvested and analyzed for IL-4, IL-13, and IFN-{gamma} production.

Removal and enrichment of Gr1+ cells

The Gr1+ cell population of PECs was removed with MACS beads. Briefly, PECs pooled from four mice were incubated with monoclonal anti-Gr-1 Ab (BD PharMingen) for 30 min at 4°C, washed two times, and reincubated with paramagnetic beads (MiniMACS, Miltenyi Biotec) coupled to goat anti-rat IgG (isotype of the anti-Gr-1 Ab) for 15 min at 4°C. PECs were washed twice and passed through a magnetic column (Miltenyi Biotec) to retain Gr1+ cells. The eluted cell fraction (<5% Gr1+ according to FACS analysis) was adjusted to 5 x 105 cells/ml and used in the cocultures as described above. The positive fraction was obtained and passed again through a new magnetic column; cells obtained here were 75% positive for Gr-1 according to FACS analysis. This population was adjusted to 5 x 105 cells/ml and used in the cocultures as described above. Furthermore, both positive and negative fractions were analyzed for morphology by cytospin as described previously (15) and stained with Giemsa stain (Sigma).

Fixed PECs, transwells cultures, and blocking Ab experiments

In some cocultures, PECs were fixed with 0.5% paraformaldehyde for 5–10 min, washed extensively with RPMI 1640, adjusted to 5 x 105/ml, and added in varying concentrations to 96-well plates in the presence of CD4+ naive cells previously stimulated with plate-bound anti-CD3/CD28 Abs. These cocultures were processed as described previously.

In other cultures, 24-well (0.4-µm pore) transwell cell culture plates (Costar) were used to separate PECs from naive CD4+ cells. PECs were plated on the superior chamber at a ratio of 1:4 to CD4+ cells, the inferior chamber was coated with anti-CD3/CD28 Abs, and naive CD4+ cells were added. Cultures were maintained for 72 h, then 1 µCi/well [3H]thymidine added (Amersham) and incubated for an additional 18 h. CD4+ cells were transferred to a 96-well plate for harvesting as described.

The role of soluble factors in PEC suppression was assayed by using varying concentrations (1, 2, and 5 µg/ml) of isotype control or blocking Abs, anti-IL-10 clone JES5-2A5, anti-IFN-{gamma} (obtained from BD PharMingen), and anti-TGF-{beta} clone 1D11 (obtained from R&D Systems), in 96-well plate cocultures, where Abs were added at the same time as PECs.

Statistical analysis

Data were analyzed with unpaired Student’s t test. Significant values were considered when p < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
LNnT-Dex injection rapidly expands Gr1+, CD11b+, and F4/80+ PECs

Previous studies demonstrated that i.p. injections of parasite Ags, eggs, or filarial parasites led to recruitment of different cell populations having a variety of activities (9, 15, 16, 17). Here, we examined the peritoneal cell response in mice after injection with the glycoconjugate LNnT-Dex at two early time points, 2 and 18 h. The peritoneal cavities of the animals were rinsed with 5 ml of cold HBSS, and PECs were harvested. Fig. 1GoA shows that at both time points, animals receiving LNnT-Dex rapidly expanded peritoneal cells compared to animals that received dextran and that at 18 h after injection, more PECs were recruited to the peritoneal cavity than at 2 h in LNnT-Dex-injected mice.



View larger version (56K):
[in this window]
[in a new window]
 
FIGURE 1. LNnT-Dex injection recruits greater numbers of peritoneal cells expressing Gr1+/CD11b+/F4/80+ surface markers. A, Number of PECs recruited at different times after a single LNnT-Dex injection. B, FACS analysis of PECs recruited by LNnT-Dex, or dextran. Mice injected with LNnT-Dex showed an increase in the markers for Gr-1/CD11b and F4/80. No changes are observed in B7-2, CD40, and CD11c (data not shown) between the different groups. PECs were obtained at different times after sugar injection. Analysis was performed in individual mice (four mice per group). Data are representative of five separate, independently performed experiments with BALB/c and C57BL/6 strains. This figure shows just the findings at 18 h after injection in BALB/c mice, this pattern was very close to those observed at 2 h and also in C57BL/6 mice at both times. C, Cytospins (x20) show a different population expanded by LNnT-Dex. PECs obtained 18 h after dextran injection (top); PECs obtained 18 h after LNnT injection (bottom). Note the increase in granulocytes. The composition of cells was 6.2% lymphocytes, 3.6% eosinophils, 39.1% neutrophils, 3.9 basophils/mast cells, and 50% macrophages in PECs from animals injected with LNnT-Dex versus 9, 1.8, 2.5, 1.8, and 84.5%, respectively, from dextran-injected mice (at least 300 cells were counted by slide).

 
The composition of the PECs was analyzed by two-color flow cytometry. Fig. 1Gob summarizes the main surface markers detected in the population expanded by LNnT-Dex. The majority of PECs were Gr1+/CD11b+ (30–40% of total cells; Fig. 1GoB) and F4/80+/Gr1+ (25–37% of total cells) compared with Gr1+ (5–7%), CD11b (28% or higher), and F4/80 (30–50%) in mice injected with Dextran or saline. In addition, LNnT-Dex-expanded Gr1+ PECs expressed low levels of B7-2, MHC-II, and CD40, and did not express CD11c, IL-10R, or NK surface markers. Percentage of composition of PECs from mice injected with LNnT-Dex or Dextran is provided in the legend for Fig. 1Go.

PECs expanded by LNnT-Dex exhibit "natural suppressor cell" activity

A number of studies have found that the expanded Gr1+/CD11b+ cell populations in animals injected with virus or in mice harboring tumors have suppressive activity and have called this population of cells "natural suppressors" (24, 25). Several other studies that used other pathogens or molecules also have correlated the expression of the Gr1+ surface marker with suppressive activity (25, 26, 27, 28). Because LNnT-Dex-expanded PECs also were Gr1+/CD11b+, we asked whether these cells had suppressive activity. We tested for suppressive activity of PECs by initially stimulating naive T cells with anti-CD3 and anti-CD28 Abs and 3 hours later adding PECs from mice injected with LNnT-Dex or dextran. PECs were added to naive CD4+ T cells at several ratios. Fig. 2Go shows that CD4+ T cells in the absence of PECs or in the presence of PECs from saline- or dextran-injected mice exhibited high levels of proliferation in response to anti-CD3/CD28 stimulation. In contrast, addition of PECs from LNnT-Dex-injected mice markedly suppressed proliferation of CD4+ cells, especially when higher ratios of PECs were added (Fig. 2Go, A and B). There was a significant inhibition in the proliferative response (50% reduction compared to controls) even when the PEC:CD4+ ratio was 1:8. However, the strongest inhibition was detected with a PEC:CD4 ratio of 1:4, where greater than 90% suppression was observed (Fig. 2Go, A and B). Suppression by LNnT-Dex-expanded PECs was observed in both BALB/c and C57BL/6 mice and was characteristic of both time points after LNnT-Dex injection at which PECs were harvested.



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 2. PECs recruited by LNnT-Dex inhibit the proliferative response of naive CD4+ cells stimulated with plate-bound anti-CD3/CD28 Abs. PECs from C57BL/6 mice (A) were obtained 2 h or from BALB/c mice (B) 18 h after injection of LNnT-Dex or dextran, cocultured at different ratios with 1 x 105 previously stimulated naive CD4+ cells. Seventy-two hours later, [3H]thymidine was added to the cultures, and after 18 h, cells were harvested and processed for radioactivity uptake. Individual mice were assayed and data are shown as mean ± SE. Results are representative of four independent experiments performed with BALB/c and C57BL/6 strains of mice at both time points. *, p < 0.05.

 
Gr1+ cells mediate suppression induced by LNnT-Dex expanded PECs

As shown in Fig. 2Go, LNnT-Dex-expanded PECs inhibit proliferation of naive CD4+ T cells in response to anti-CD3/CD28 stimulation. To identify the cell type responsible for this suppressive activity, we depleted or enriched PECs for Gr1+ cells by magnetic cell sorting and tested the negative and positive fractions in PEC:CD4+ cocultures. We found that suppression mediated by LNnT-Dex PECs was significantly abolished (p < 0.01; Fig. 3Goa) when Gr1+ cells were removed (<5%; Fig. 3Gob) from the population, indicating that Gr1+ PECs mediate suppression. In contrast, with PECs enriched for Gr1+ cells (76% by FACS analysis; Fig. 3GoB) we observed that the Gr1+-enriched population exhibited higher levels of inhibition than that observed with the total PEC population, even when lower PECs:CD4+ ratios were used (Fig. 3GoA).



View larger version (38K):
[in this window]
[in a new window]
 
FIGURE 3. Depletion of Gr1+ cells from PECs recruited by LNnT-Dex restores the proliferative response to anti-CD3/CD28 Abs in naive CD4+ cells, whereas the enrichment of Gr1+ cells maintain the suppressor activity. A, PECs recruited by LNnT-Dex or dextran were harvested, pooled, and depleted or enriched for Gr1+ cells by MACS and added in a ratio 1:4 or 1:8 to naive CD4+ cells previously stimulated with anti-CD3/CD28. Cells were cocultured for 72 h, and incorporation of [3H]thymidine was measured. Results are the average of triplicates ± SE and are representative of three separate experiments performed in BALB/c and C57BL/6 mice. *, p < 0.05. B, Depletion of Gr1 cells (left) was more than 94%, whereas the enriched Gr1+ (right) fraction reached a purity of 76%. C, Photomicrograph of cytospin showing the morphology of PECs fractions, Gr-1- fraction (top; x20); Gr-1+ fraction (bottom, x40).

 
Analysis of the various PEC fractions via cytospin demonstrated an absence of eosinophils, mast cells, and lymphocytes in the suppressor activity of PECs, as these cells were found in the Gr-1- fraction (Fig. 3GoC). This observation suggested that suppressor activity was attributable to macrophages or neutrophils in the Gr-1+ fraction (Fig. 3GoC, bottom).

Suppression is mediated by both cell contact and by soluble factors

We next tested for mechanisms involved in the suppressive activity of PECs. Initially, we asked if fixed cells would retain suppressor activity. PECs from LNnT-Dex- or dextran-injected mice were harvested, adjusted to 5 x 105/ml, and fixed with 0.5% paraformaldehyde for 5–10 min. PECs then were washed extensively and added to previously (3 h) stimulated naive CD4+ cells. Interestingly, fixed PECs from LNnT-Dex-injected mice were able to partially inhibit the proliferation of anti-CD3/CD28-stimulated CD4+ cells (Fig. 4GoA). The level of inhibition was not as high as that observed in live PECs in cocultures but was significantly greater than that observed for control fixed PECs (p < 0.05), demonstrating that cell-to-cell interactions are partially responsible for the observed suppression. We next addressed the possibility that soluble factors also may participate in PEC-mediated suppression. In these experiments, transwells were used to eliminate cell-to-cell contact in PEC:CD4+ cocultures. PECs were plated in the upper chamber at a ratio of 1:4 with respect to naive CD4+ cells, which were plated and stimulated in the lower chamber with anti-CD3/CD28 plate-bound Abs. The transwell cocultures showed that even in the absence of cell-to-cell contact, there was significant inhibition in the proliferation of anti-CD3/CD28-stimulated CD4+ cells (~50% inhibition; Fig. 4GoB; p < 0.05), suggesting a role for soluble factors in Gr1+ PEC-mediated suppression of T cell proliferation.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 4. Proliferative inhibition by PECs recruited by LNnT-Dex can be mediated by both cell-to-cell contact and by soluble factors. PECs harvested at 2 or 18 h after sugar injection were either fixed with 0.5% of paraformaldehyde before being directly cocultured with CD4 naive cells (A) or placed in a separate transwell plate separated by a 0.4-µm membrane (B). PECs were obtained from individual mice, and triplicate wells were set up. Proliferation was measured by [3H]thymidine uptake. Data are shown as mean ± SE from four animals per group and are representative of three independent experiments. *, p < 0.05.

 
PECs expanded by LNnT-Dex secrete a different profile of cytokines than control PECs

To determine if LNnT-Dex injection biased as well as activated PECs, we examined the spontaneous cytokine profiles from peritoneal cells at 2 h or 18 h after injection of LNnT-Dex or dextran in Th1-type (C57BL/6) and Th2-type (BALB/c) mice. After 72 h of culture, supernatants were harvested and analyzed. The results revealed that injection of LNnT-Dex profoundly altered the pattern of cytokines spontaneously released by PECs compared to PECs from dextran-injected mice, regardless of the strain. PECs expanded by LNnT-Dex produced significantly lower levels of the proinflammatory cytokines IL-1{beta}, IL-12, IL-18, and IFN-{gamma}, and in contrast, higher levels of IL-10 and TGF-{beta} than PECs from dextran-injected mice (Tables IGo and IIGo). We did not detect significant levels of PGE2 or nitric oxide from either population of PECs (data not shown). Thus, LNnT-Dex not only expands Gr1+/F4/80+ suppressor cells, but activates these cells towards an antiinflammatory cytokine profile in both Th1- and Th2-type strains of mice.


View this table:
[in this window]
[in a new window]
 
Table I. Spontaneous proinflammatory cytokine production by PECs recruited by LNnT or dextran in BALB/c or C57BL/6 mice1

 

View this table:
[in this window]
[in a new window]
 
Table II. Spontaneous production of antiinflammatory cytokines by PECs recruited by LNnT or Dextran in BALB/c or C57BL/6 mice1

 
PECs expanded by LNnT-Dex inhibit IFN-{gamma} production in cocultures with naive CD4+ T cells while enhancing the production of IL-13

Previous studies on natural suppressor cells suggested that after interaction with suppressors, CD4 or CD8 target cells undergo apoptosis (24, 25, 26). To exclude the possibility that CD4+ cells in our cocultures had reduced proliferation attributable to cell death, we measured cytokine production in response to anti-CD3/CD28 stimulation in the presence of PECs. We found that there was a significant decrease in IFN-{gamma} production in supernatants from cocultures containing PECs expanded by LNnT-Dex compared to PECs from dextran-injected or noninjected mice (Fig. 5GoA; p < 0.05). Additionally, we observed that levels of IL-13 were significantly elevated in cocultures with LNnT-Dex-expanded PECs compared to cultures containing dextran-recruited PECs (Fig. 5GoB; p < 0.01). Furthermore, IL-4 levels were increased from 587 ± 130 pg/ml to 1227 ± 337 pg/ml in cocultures containing LNnT-Dex-expanded PECs. These results demonstrate that cocultured CD4+ cells are alive and that PECs expanded by LNnT-Dex can alter the cytokine profile of naive CD4+ T cells.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 5. PECs recruited by LNnT-Dex modify the cytokine profile of CD4+ cells stimulated with anti-CD3/CD28 Abs. PECs from animals injected with LNnT-Dex or dextran were cocultured with CD4+ naive cells, after 72 h the IFN-{gamma} (A) and IL-13 production (B) were assayed by ELISA. Error bars are ± SD. *, p < 0.05.

 
LNnT-Dex Gr1+ suppressor cells "imprint" a Th2 phenotype on naive CD4+ T cells

We found that PEC-mediated suppression of naive CD4+ T cells could be reversed by removal of Gr1+ PECs, and further, that cocultured CD4+ T cells were viable and responsive when PECs were removed. Secondly, we found that supernatants from cocultures were biased in a Th2-type, anti-inflammatory mode. Therefore, we asked if cocultured CD4+ cells would respond to secondary stimulation and whether initial culture with Gr1+ suppressor cells "imprinted" a Th1- or Th2-type response on the CD4+ T cells. After 72 h of coculture, cells were removed, washed, and CD4+ cells repurified. Purified CD4+ cells then were plated and incubated for 72 h (rested), and then stimulated with anti-CD3/CD28 plate-bound Abs in the absence of PECs. Supernatants were harvested 24 h later. Similar to what was detected in the primary coculture supernatants, we found that rested and restimulated CD4 cells produced low levels of IFN-{gamma} (Fig. 6GoA) and in contrast, produced high levels of IL-13 (Fig. 6GoB). These data provide additional evidence that CD4+ cells in cocultures are alive, and furthermore, suggest that the majority of T cells isolated after primary coculture with LNnT-Dex-PECs are Th2 committed, as the highest levels of IL-13 were secreted after secondary stimulation (29). In parallel experiments, we found that the addition of IL-12 to cocultures partially restored IFN-{gamma} production as detected in supernatants, providing further evidence that cocultured CD4+ cells are alive and able to respond to external stimuli (data not shown). In addition, exogenous IL-12 in cocultures also reduced the levels of IL-13. Although this suggests that these cells have an imprinted Th2-like phenotype, additional and more detailed experiments need to be performed to verify this important observation.



View larger version (11K):
[in this window]
[in a new window]
 
FIGURE 6. Suppressive PECs recruited by LNnT-Dex commit CD4 cells to produce more IL-13 in a secondary stimulation. CD4 naive cells were previously stimulated with plate bound anti-CD3/CD28 and 3 h later PECs (ratio 1:4) recruited by LNnT-Dex or dextran were added to cultures in the absence of IL-12. After 3 days, primed CD4 cells were washed, repurified, rested for three more days and re-stimulated with anti-CD3/CD28 Abs. Twenty-four hours after secondary stimulation supernatants were assayed for IFN-{gamma} (A) and IL-13 (B) production. Data are representative of three experiments performed in BALB/c mice, and show mean ± SE of triplicate cultures of four mice assayed individually. *, p < 0.05.

 
Blockade of IL-10, but not of TGF-{beta}, partially abrogates suppression activity in PECs recruited by LNnT-Dex

Because a significant inhibitory effect was shown in experiments where PECs:CD4+ cocultures were performed with transwells and because LNnT-Dex PECs produced high levels of IL-10 and TGF-{beta}, we performed neutralization experiments to determine whether either of these molecules classically associated with inhibitory effects (30, 31, 32, 33) were involved in suppression. As shown in Fig. 7Go, neutralization of IL-10 resulted in a partial decrease (30%; p < 0.05) in the ability of the LNnT-Dex PECs to suppress CD4+ cell proliferation. In contrast, neutralizing Abs against TGF-{beta}1, TGF-{beta}2, and TGF-{beta}3 had no significant effect on cellular proliferation (Fig. 7Go). This suggests that IL-10 plays a modest role as a soluble factor in the suppressive activity associated with LNnT-Dex-expanded PECs.



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 7. IL-10, IFN-{gamma}, and NO are involved in the soluble-mediated suppressive activity of PECs expanded by LNnT-Dex. Cocultures of PECs and CD4+ (1:4 ratio) were performed as described in Material and Methods, and neutralizing monoclonal anti-IL-10, anti-IFN-{gamma}, or anti-TGF-{beta} Abs were added to the in vitro cocultures. Furthermore, a NO inhibitor (LnMMA, 0.5 mM) was tested. After 72 h, proliferation was measured by [3H]thymidine uptake. Data are representative of three different experiments performed in BALB/c mice and show mean ± SE of triplicate cultures of four mice assayed individually. *, p < 0.05 compared to PECs-dextran.

 
Blockade of IFN-{gamma} and NO abrogates suppressive activity in PECs expanded by LNnT-Dex

The majority of studies on Gr1 suppressors have shown that suppression is an IFN-{gamma} and NO-dependent process (30, 34, 35). Because blocking IL-10 in cocultures was unable to completely restore proliferative activity in CD4+ cells, we asked if LNnT-Dex-expanded Gr1 suppressors functioned in an IFN-{gamma}- and NO-dependent mechanism. As shown in Fig. 7Go, both the neutralization of IFN-{gamma} and the inhibition of NO via N-monomethyl-L-arginine completely restored the proliferative response of CD4+ cells. Taken together with the partial reversal of suppression by neutralizing IL-10, it appears that LNnT-Dex-expanded Gr1 suppressors function via several factors to suppress naive CD4+ T cells.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We initiated the studies presented here to expand on our earlier observations that two schistosome glycoconjugates are involved in Th2-biasing of the host immune response and are inducers of suppression/anergy (21, 22). To investigate whether the immune biasing provoked by LNnT-Dex is related to a specific cell population, and furthermore, by early innate immune responses, we developed a series of ex-vivo experiments to decipher the early response to LNnT-Dex. Several studies have reported inhibition of T cell responses by a cell population identified phenotypically as Gr1+/CD11b+. These cells have been termed natural suppressor cells or immature myeloid cells and appear to be mediating immunosuppressive effects in a wide variety of unrelated pathological conditions (24, 25, 26, 27, 28, 29, 34, 35, 36, 37). In light of the reports on natural suppressor cells, we asked if the immunomodulatory glycoconjugate LNnT-Dex would expand suppressor cells in otherwise naive mice.

In this study, we observed that Gr1+ suppressor cells were rapidly expanded in the peritoneal cavities of naive mice after a single injection of the glycoconjugate LNnT-Dex, of which LNnT is found in human milk and on helminth parasites. Injection of LNnT-Dex into naive mice expanded Gr1+/CD11b+/F4/80+ cells as early as 2 h after injection compared to dextran- or saline-injected controls. This rapid expansion of Gr1 suppressors has not been reported in previous studies on natural suppressors; rather, these other reports showed that Gr1+ suppressor expansion took from days to weeks in animals harboring parasites or tumors or exposed to virus or viral antigens (24, 25, 28, 35). In addition, we noted that this population was maintained in vivo for at least 24 h after injection of LNnT-Dex. The rapid increase in frequency of Gr1+ suppressors by LNnT-Dex suggests that the glycoconjugate functions via an innate immune response.

LNnT-Dex-expanded PECs were functional suppressors, as they adoptively suppressed a primary, naive CD4+ T cell response to anti-CD3 and anti-CD28 Abs. Suppression was shown to be dependent on the presence of Gr1+ cells, as removal of Gr1+ cells from the PEC population rendered the remaining PECs unable to suppress CD4+ cell proliferation, even when cocultured at a 1:2 ratio of PECs:CD4+ cell. In contrast, the Gr1+-enriched cell fraction maintained strong suppressive activity, confirming a suppressor role for cells carrying this marker. When performing cocultures to test suppressor activity of PECs, we used a ratio of PECs:CD4+ T cells that was similar/identical to those used in other studies where tumors or virus were used to expand Gr1+ suppressors (24, 25, 28, 34, 35). These ratios are in contrast to the only other study examining suppressor PECs generated by parasitic helminths. In that study, the ratio of PECs to target cells was 10- to 100-fold higher than the ratio used in our study (15).

Mechanistically, we demonstrated that Gr1+ suppressor cells functioned via both cell-to-cell contact and through the release of soluble factors. Thus, although paraformaldehyde-fixed PECs did not suppress naive CD4+ cells at the same level as nonfixed PECs, they did reduce CD4+ T cell proliferation well below the level seen with nonfixed PECs from dextran-injected mice. This finding indicates that a molecule(s) associated with PEC membranes is involved in suppression, and furthermore, that they are rapidly up-regulated on the cell surface after interaction with LNnT-Dex. However, cell contact alone was not sufficient for optimal suppression, and our transwell experiments demonstrated a role for soluble factors, where IL-10, IFN-{gamma}, and NO appear to be involved, but not TGF-{beta}. The soluble factors implicated in our study are similar to those seen in other suppressor cell populations induced by pathogens that have been shown to be contact-, IFN-{gamma}- and NO-dependent (26, 27, 34). Of note, the PECs expanded by LNnT-Dex or dextran did not spontaneously release NO in culture (data not shown); however, when cultured with IFN-{gamma} producing CD4+ cells, they release NO. Release of NO by macrophages or myeloid cells following cell contact is a process normally mediated by CD40 ligation (34). Although we cannot rule out a role for CD40 here, FACScan analysis showed that CD40 was expressed at low levels on LNnT-Dex-expanded Gr1+ suppressor cells. Perhaps the strongest argument against a required role for CD40 are our preliminary studies in CD40 knockout mice, which show that LNnT-Dex expands functional Gr1+ suppressors in these mice (data not shown). Finally, in regards to mechanisms of suppression, the majority of other studies have shown that the target population (CD4+/CD8+) undergoes apoptosis after contact with Gr1+ suppressors (24, 25, 26, 27, 32). In contrast, we found that CD4+ cells were viable after coculture with Gr1+ suppressors, and that after rest and restimulation, supernatants obtained from cocultures contained high levels of cytokines, indicating that the cells were alive. One of the more striking observations from the coculture experiments was that rested and restimulated CD4+ T cells maintained the profile of cytokine production seen in the initial cocultures, which was low levels of IFN-{gamma} and high levels of IL-13 compared with their respective controls. Taken together, these data support the fact that CD4+ cells remain viable in the presence of PECs recruited by LNnT-Dex and that the Gr1+ suppressor cells may "imprint" a Th2 phenotype on naive CD4+ cells.

Though our results differed in both the time required to expand Gr1+ suppressors as well as the ratio of PECs:CD4+ cells used in cocultures, our results on mechanism of suppression are in accordance with the findings of MacDonald et al. (16) and Loke et al. (15) who implanted the nematode Brugia malayi in the peritoneal cavity of mice to expand suppressors macrophages. Loke et al. (15) also showed that cytokine production in their system was skewed towards Th2-type concomitant with suppression in the proliferative response (36). These studies suggest that the commitment towards a Th2 pattern of cytokine production by CD4+ cells after interaction with PEC suppressors may explain the reduced levels of IFN-{gamma} and IL-12 observed in certain helminth infections.

The mechanism used by the granulocyte-monocyte lineage to differentially inhibit the function of CD4+ T cells is not yet well understood (34, 35). We currently are investigating several hypotheses on suppressive mechanism and imprinting of Th2-type phenotype on naive T cells in coculture. Although we were able to show that soluble factors such as IL-10, IFN-{gamma}, and NO were involved in suppression, we were surprised to find that blockade of TGF-{beta}, a cytokine known to induce suppression in activated T cells (31, 38) did not restore CD4+ proliferation. However, the suppressive effect of TGF-{beta} is not restricted to inhibition of proliferative responses, but in addition, it has the ability to modulate the profile of activating cytokines, such as limiting the production of IFN-{gamma} (31, 38). In our system, the LNnT-Dex-induced PECs produced high levels of TGF-{beta}, which may have been partly responsible for the reduced levels of IFN-{gamma}. In contrast to TGF-{beta}, IL-10 did have a small effect in suppression as shown in the neutralizing Ab experiments. The ability of parasite-expressed glycoconjugates to induce production of IL-10 and TGF-{beta} may be a major mechanism used by the parasite to avoid both a strong and an early cellular immune response during infection. This correlates with our results that showed that the helminth- and human milk-expressed sugar LNFPIII could be added in vitro to down-modulate IL-10 production in PBMCs from patients infected with S. mansoni (39). Taken together, PECs expanded by the immuno-modulatory glycoconjugate LNnT-Dex produce two key cytokines with suppressive or anti-inflammatory activity, IL-10 and TGF-{beta}, which are capable of counterbalancing the proinflammatory cytokines IL-1{beta}, IL-12, IL-18, and IFN-{gamma} (30, 40, 41). As both LNnT and LNFPIII expand suppressor cells and drive IL-10 production and are also found in human milk, which is immunosuppressive, we speculate that the immunosuppressive properties of human milk are attributable in part to the presence of these two glycoconjugates (23).

The rapid and local responses to the LNnT-Dex glycoconjugate that we have shown suggests that these sugars may function therapeutically when an effective and fast anti-inflammatory response is needed, or as a potential adjuvant to induce Th2 responses later in disease progression. The precise nature of cells responsible for the suppressive effect reported here is presently under further investigation. We already have shown that a Gr1+ population is directly related to suppression. Furthermore, low or absent expression of MHC-class II, CD40, and B7-2 detected in the Gr1+ population suggest an immature myeloid cell type (36). A similar cell population has been found from bone marrow that induces hyporesponsiveness in allogenic T cells (34) and immune dysfunction in cancer (37).

Collectively, we presented data demonstrating that an immunomodulatory glycoconjugate (LNnT-Dex) comprised of a tetrasaccharide found on helminth parasites and in human milk rapidly expands a suppressor cell population that, similar to previous reports, mediates suppression via an IFN-{gamma}- and NO-dependent mechanism, but unlike other reports, also may use IL-10. The biological significance of suppressor cells, which are expanded by parasite-expressed carbohydrates in helminth and other infections, remains to be investigated. It is known that immunodominant epitopes found on glycoproteins and glycolipids are often periodate sensitive (42, 45), implicating a role for glycosylated epitopes in the host-parasite interaction (46, 47). In light of our observations, we suggest that these immunoregulatory oligosaccharides found in milk and on helminth-expressed glycoconjugates may have additional roles in driving early immunological events towards Th2-type or antiinflammatory responses, and furthermore, that these molecules represent novel potential therapeutic agents for the treatment of Th1-mediated autoimmune diseases as well as any type of proinflammatory condition.


    Footnotes
 
1 Address correspondence and reprint requests to Dr. Luis I. Terrazas, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Building 1, Room 802, 665 Huntington Avenue, Boston, MA 02115. E-mail address: lterraza{at}hsph.harvard.edu Back

2 Abbreviations used in this paper: LNFPIII, lacto-N-fucopentaose; LNnT, lacto-N-neotetraose; LNnT-Dex, LNnT-dextran; PEC, peritoneal exudate cells. Back

Received for publication March 8, 2001. Accepted for publication August 22, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Orme, I., A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 20:307.[Medline]
  2. Aliberti, J., C. Reis e Sousa, M. Schito, S. Hieny, T. Wells, G. B. Huffnagle, A. Sher. 2000. CCR5 provides a signal for microbial induced production of IL-12 by CD8a+ dendritic cells. Nat. Immunol. 1:83.[Medline]
  3. Brombacher, F., A. Dorfmuller, J. Magram, W. J. Dai, G. Kohler, A. Wunderlin, K. Palmer-Lehman, M. K. Gately, G. Alber. 1999. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11:325.[Abstract/Free Full Text]
  4. Bliss, S. K., A. J. Marshall, Y. Zhang, E. Y. Denkers. 1999. Human polymorphonuclear leukocytes produce IL-12, TNF-{alpha} and the chemokines macrophage inflammatory protein 1-{alpha} and 1{beta} in response to Toxoplasma gondii antigens. J. Immunol. 162:7369.[Abstract/Free Full Text]
  5. Meyer Zum Buschenfelde, C., S. Cramer, C. Trumpheller, B. Fleisher, S. Frosch. 1997. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with IFN-{gamma} production. Clin. Exp. Immunol. 110:378.[Medline]
  6. Chiaramonte, M. G., L. R. Schopf, T. Y. Neben, A. W. Cheever, D. D. Donaldson, T. Wynn. 1999. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162:920.[Abstract/Free Full Text]
  7. Maizels, R. M., D. A. P. Bundy, M. E. Silkirk. 1993. Immunological modulation and evasion by helminth parasites in human populations. Nature 365:797.[Medline]
  8. Grogan, J. L., P. E. Kremsner, A. M. Deelder, M. Yazdanbakhsh. 1998. Antigen-specific proliferation and interferon-{gamma} and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J. Infect. Dis. 177:1433.[Medline]
  9. Fallon, P. G.. 2000. Immunopathology of schistosomiasis: a cautionary tale of mice and men. Immunol. Today 21:29.[Medline]
  10. Actor, J. K., S. Mutsunori, M. C. Kullberg, A. Sher. 1993. Helminth infection results in decreased specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA 90:948.[Abstract/Free Full Text]
  11. Kullberg, M. C., E. J. Pearce, S. E. Hieny, A. Sher. 1992. Infection with Schistosoma mansoni alters Th1/Th2 cytokine response to a non-parasite antigen. J. Immunol. 148:3264.[Abstract]
  12. Pearlman, E., W. J. Kazura, E. F. Hazlett, H. W. Boom. 1993. Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J. Immunol. 151:4857.[Abstract]
  13. Rodriguez, M., L. I. Terrazas, R. Marquez, R. Bojalil. 1999. Susceptibility to Trypanosoma cruzi is modified by a previous non-related infection. Parasite Immunol. 21:177.[Medline]
  14. Curry, A. J., K. J. Else, F. Jones. 1995. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J. Exp. Med. 181:769.[Abstract/Free Full Text]
  15. Loke, P., A. S. MacDonald, A. Robb, R. M. Maizels, J. E. Allen. 2000. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell to cell contact. Eur. J. Immunol. 30:2669.[Medline]
  16. MacDonald, A. S., R. M. Maizels, R. A. Lawrence, I. Dransfield, J. E. Allen. 1998. Requirement for in vivo production of IL-4, but not IL-10 in the induction of proliferative suppression by filarial parasites. J. Immunol. 160:1304.[Abstract/Free Full Text]
  17. Holland, M. J., Y. M. Harcys, P. L. Riches, R. M. Maizels. 2000. Proteins secreted by the parasitic nematode Nippostrongylus brasiliensis act as adjuvants for Th2 responses. Eur. J. Immunol. 30:1977.[Medline]
  18. Spolski, R. J., J. Corson, P. G. Thomas, R. E. Kuhn. 2000. Parasite-secreted products regulate the host response to larval Taenia crassiceps. Parasite Immunol. 22:297.[Medline]
  19. Okano, H., A. R. Satoskar, D. A. Harn. 1999. Th2 type response induced by soluble egg antigen is largely due to carbohydrates. J. Immunol. 163:6712.[Abstract/Free Full Text]
  20. Grzych, J. M., E. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Hieny, F. Lewis, A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1322.[Abstract]
  21. Vellupillai, P., W. E. Secor, A. M. Horauf, D. A. Harn. 1997. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polyactosamine sugars. J. Immunol. 158:338.[Abstract]
  22. Okano, M., A. R. Satoskar, K. Nishizaki, D. A. Harn. 2001. Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J. Immunol. 167:442.[Abstract/Free Full Text]
  23. Kunz, C., S. Rudloff. 1993. Biological functions of oligosaccharides in human milk. Acta Paediatr. 82:903.[Medline]
  24. Bronte, V., M. Wang, E. Apoloni, A. Cabrelle, P. Hwu, N. P. Restifo. 1998. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr1+ cells. J. Immunol. 161:5313.[Abstract/Free Full Text]
  25. Kusmartsev, S. A., Y. Li, S. H. Chen. 2000. Gr1+ myeloid cells derived from tumor bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165:779.[Abstract/Free Full Text]
  26. Apolloni, E., V. Bronte, A. Mazzoni, P. Serafini, A. Cabrelle, D. M. Segal, H. A. Young, P. Zanovello. 2000. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 165:6723.[Abstract/Free Full Text]
  27. Cauley, L. S., E. E. Miller, M. Yen, S. L. Swain. 2000. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-{gamma}. J. Immunol. 165:6056.[Abstract/Free Full Text]
  28. Bronte, V., D. B. Cahppek, E. Apoloni, A. Cabrelle, M. Wang, P. Hwu, N. P. Restifo. 1999. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell response by dysregulating antigen presenting cell maturation. J. Immunol. 162:5728.[Abstract/Free Full Text]
  29. Constant, S. L., K. Bottomly. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.[Medline]
  30. Pelaez, B., J. A. Campillo, J. A. Lopez-Asenjo, J. L. Subiza. 2001. Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism. J. Immunol. 166:6608.[Abstract/Free Full Text]
  31. Letterio, J. J., A. B. Roberts. 1998. Regulation of the immune responses by TGF-{beta}. Annu. Rev. Immunol. 16:137.[Medline]
  32. Gazzinelli, R. T., I. P. Oswald, S. L. James, A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-{gamma}-activated macrophages. J. Immunol. 148:1792.[Abstract]
  33. O’Farrel, A. M., Y. Liu, K. W. Moore, A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17:1006.[Medline]
  34. Angulo, I., J. Rullas, J. A. Campillo, E. Obregon, A. Heath, M. Howard, M. A. Munoz-Fernandez, J. L. Subiza. 2000. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-{gamma} stimulation through a mechanism dependent on endogenous TNF-{alpha} and IL-1{alpha}. Eur. J. Immunol. 30:1263.[Medline]
  35. Gabrilovich, D. I., M. P. Velders, E. M. Sotomayor, W. M. Kast. 2001. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cell. J. Immunol. 166:5398.[Abstract/Free Full Text]
  36. Loke, P., A. S. MacDonald, J. E. Allen. 2000. Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naive CD4 T cells. Eur. J. Immunol. 30:1127.[Medline]
  37. Salvadori, S., G. Martinelli, K. Zier. 2000. Resection of solid tumors reverses T cell defects and restores protective immunity. J. Immunol. 164:2214.[Abstract/Free Full Text]
  38. Ludviksson, B. R., D. Seegers, A. S. Resnick, W. Strober. 2000. The effect of TGF-{beta}1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol. 30:2101.[Medline]
  39. Velupillai, P., E. A. Dos Reis, M. G. dos Reis, D. A. Harn. 2000. Lewisx-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis. Hum. Immunol. 61:225.[Medline]
  40. Li, J., C. A. Hunter, J. P. Farrell. 1999. Anti-TGF-{beta} treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162:974.[Abstract/Free Full Text]
  41. Rojas, E. R., K. Balaji, A. Subramanian, H. Boom. 1999. Regulation of human CD4+ {alpha}{beta} T-cell-receptor-positive (TCR+) and {gamma}{delta} TCR+ T-cell responses to Mycobacterium tuberculosis by IL-10 and transforming growth factor {beta}. Infect. Immun. 67:6461.[Abstract/Free Full Text]
  42. Wuhrer, M., R. D. Dennis, M. J. Doenhoff, Q. Bickle, G. Lochnit, R. Geyer. 1999. Immunochemical characterization of Schistosoma mansoni glycolipid antigens. Mol. Biochem. Parasitol. 103:155.[Medline]
  43. Restrepo, B. I., A. Obregón-Henao, M. Mesa, D. L. Gil, B. L. Ortiz, J. S. Mejia, G. E. Villota, F. Sansón, J. M. Teale. 2000. Characterization of the carbohydrate components of Taenia solim metacestode glycoprotein antigens. Int. J. Parasitol. 30:689.[Medline]
  44. Feizi, T.. 2000. Carbohydrate-mediated recognition systems in innate immunity. Immunol. Rev. 173:79.[Medline]
  45. Khoo, K. H., D. Chatterjee, J. P. Caulfield, H. R. Morris, A. Dell. 1997. Structural characterization of glycosphingolipids from eggs of Schistosoma mansoni and S. japonicum. Glycobiology 7:653.[Abstract/Free Full Text]
  46. Nyame, A. K., R. Debnose-Boyd, T. D. Long, V. Tsang, R. D. Cummings. 1998. Expression of Lex antigen in S. japonicum and S. haematobium and immune responses to Lex in infected animals: lack of Lex expression in other trematodes and nematodes. Glycobiology 8:615.[Abstract/Free Full Text]
  47. Wuhrer, M., R. D. Dennis, M. J. Doenhoff, Q. Bickle, G. Lochnit, R. Geyer. 2000. Schistosoma mansoni cercarial glycolipids are dominated by Lewis X and pseudo Lewis Y structures. Glycobiology 10:89.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
BloodHome page
J. Bystrom, I. Evans, J. Newson, M. Stables, I. Toor, N. van Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, and D. W. Gilroy
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP
Blood, November 15, 2008; 112(10): 4117 - 4127.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. Boehm and G. Moro
Structural and Functional Aspects of Prebiotics Used in Infant Nutrition
J. Nutr., September 1, 2008; 138(9): 1818S - 1828S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Arslanoglu, G. E. Moro, and G. Boehm
Early Supplementation of Prebiotic Oligosaccharides Protects Formula-Fed Infants against Infections during the First 6 Months of Life
J. Nutr., November 1, 2007; 137(11): 2420 - 2424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Smith, N. E. Mangan, C. M. Walsh, R. E. Fallon, A. N. J. McKenzie, N. van Rooijen, and P. G. Fallon
Infection with a Helminth Parasite Prevents Experimental Colitis via a Macrophage-Mediated Mechanism
J. Immunol., April 1, 2007; 178(7): 4557 - 4566.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. Boehm and B. Stahl
Oligosaccharides from Milk
J. Nutr., March 1, 2007; 137(3): 847S - 849S.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Ezernitchi, I. Vaknin, L. Cohen-Daniel, O. Levy, E. Manaster, A. Halabi, E. Pikarsky, L. Shapira, and M. Baniyash
TCR {zeta} Down-Regulation under Chronic Inflammation Is Mediated by Myeloid Suppressor Cells Differentially Distributed between Various Lymphatic Organs
J. Immunol., October 1, 2006; 177(7): 4763 - 4772.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. S. Duffy, H. R. Morris, A. Dell, J. A. Appleton, and S. M. Haslam
Protein glycosylation in Parelaphostrongylus tenuis--first description of the Gal{alpha}1-3Gal sequence in a nematode
Glycobiology, September 1, 2006; 16(9): 854 - 862.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
O. Atochina and D. Harn
LNFPIII/LeX-Stimulated Macrophages Activate Natural Killer Cells via CD40-CD40L Interaction
Clin. Vaccine Immunol., September 1, 2005; 12(9): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Brys, A. Beschin, G. Raes, G. H. Ghassabeh, W. Noel, J. Brandt, F. Brombacher, and P. D. Baetselier
Reactive Oxygen Species and 12/15-Lipoxygenase Contribute to the Antiproliferative Capacity of Alternatively Activated Myeloid Cells Elicited during Helminth Infection
J. Immunol., May 15, 2005; 174(10): 6095 - 6104.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Raes, L. Brys, B. K. Dahal, J. Brandt, J. Grooten, F. Brombacher, G. Vanham, W. Noel, P. Bogaert, T. Boonefaes, et al.
Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation
J. Leukoc. Biol., March 1, 2005; 77(3): 321 - 327.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Donnelly, S. M. O'Neill, M. Sekiya, G. Mulcahy, and J. P. Dalton
Thioredoxin Peroxidase Secreted by Fasciola hepatica Induces the Alternative Activation of Macrophages
Infect. Immun., January 1, 2005; 73(1): 166 - 173.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G L Radford-Smith
Will worms really cure Crohn's disease?
Gut, January 1, 2005; 54(1): 6 - 8.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
G. Borkow and Z. Bentwich
Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy
Clin. Microbiol. Rev., October 1, 2004; 17(4): 1012 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M.-B. Voisin, D. Buzoni-Gatel, D. Bout, and F. Velge-Roussel
Both Expansion of Regulatory GR1+ CD11b+ Myeloid Cells and Anergy of T Lymphocytes Participate in Hyporesponsiveness of the Lung-Associated Immune System during Acute Toxoplasmosis
Infect. Immun., September 1, 2004; 72(9): 5487 - 5492.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Smith, C. M. Walsh, N. E. Mangan, R. E. Fallon, J. R. Sayers, A. N. J. McKenzie, and P. G. Fallon
Schistosoma mansoni Worms Induce Anergy of T Cells via Selective Up-Regulation of Programmed Death Ligand 1 on Macrophages
J. Immunol., July 15, 2004; 173(2): 1240 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Li, P.-Y. Pan, P. Gu, D. Xu, and S.-H. Chen
Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity
Cancer Res., February 1, 2004; 64(3): 1130 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Tawill, L. Le Goff, F. Ali, M. Blaxter, and J. E. Allen
Both Free-Living and Parasitic Nematodes Induce a Characteristic Th2 Response That Is Dependent on the Presence of Intact Glycans
Infect. Immun., January 1, 2004; 72(1): 398 - 407.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Walker, A. Baz, S. Dematteis, M. Stettler, B. Gottstein, J. Schaller, and A. Hemphill
Isolation and Characterization of a Secretory Component of Echinococcus multilocularis Metacestodes Potentially Involved in Modulating the Host-Parasite Interface
Infect. Immun., January 1, 2004; 72(1): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Chiffoleau, T. Kobayashi, M. C. Walsh, C. G. King, P. T. Walsh, W. W. Hancock, Y. Choi, and L. A. Turka
TNF Receptor-Associated Factor 6 Deficiency during Hemopoiesis Induces Th2-Polarized Inflammatory Disease
J. Immunol., December 1, 2003; 171(11): 5751 - 5759.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. C. Zimring, S. B. Levery, B. Kniep, L. M. Kapp, M. Fuller, and J. A. Kapp
CD75s is a marker of murine CD8+ suppressor T cells
Int. Immunol., November 1, 2003; 15(11): 1389 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. G. Hogg, S. Kumkate, S. Anderson, and A. P. Mountford
Interleukin-12 p40 Secretion by Cutaneous CD11c+ and F4/80+ Cells Is a Major Feature of the Innate Immune Response in Mice That Develop Th1-Mediated Protective Immunity to Schistosomamansoni
Infect. Immun., June 1, 2003; 71(6): 3563 - 3571.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
I. van Die, S. J. van Vliet, A. K. Nyame, R. D. Cummings, C. M.C. Bank, B. Appelmelk, T. B.H. Geijtenbeek, and Y. van Kooyk
The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x
Glycobiology, June 1, 2003; 13(6): 471 - 478.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
V. Balloy, J.-M. Sallenave, B. Crestani, M. Dehoux, and M. Chignard
Neutrophil DNA Contributes to the Antielastase Barrier during Acute Lung Inflammation
Am. J. Respir. Cell Mol. Biol., June 1, 2003; 28(6): 746 - 753.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Liu, J. A. Van Ginderachter, L. Brys, P. De Baetselier, G. Raes, and A. B. Geldhof
Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells
J. Immunol., May 15, 2003; 170(10): 5064 - 5074.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Rodriguez-Sosa, A. R. Satoskar, R. Calderon, L. Gomez-Garcia, R. Saavedra, R. Bojalil, and L. I. Terrazas
Chronic Helminth Infection Induces Alternatively Activated Macrophages Expressing High Levels of CCR5 with Low Interleukin-12 Production and Th2-Biasing Ability
Infect. Immun., July 1, 2002; 70(7): 3656 - 3664.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terrazas, L. I.
Right arrow Articles by Harn, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terrazas, L. I.
Right arrow Articles by Harn, D. A., Jr.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS